Media, investors, advocacy organizations and others, please contact us here.

Events Nephrology

World Congress of Nephrology (WCN)

Information Type

Event Materials 4

Posters IgAN

Sparsentan Reduces Proteinuria in Patients With Immunoglobulin A Nephropathy (IgAN): Interim Results of the Protect Study

Posters IgAN

Sparsentan Reduces Proteinuria in Patients With Immunoglobulin A Nephropathy (IgAN): Interim Results of the PROTECT Study

Posters IgAN

Immunoglobulin A Nephropathy (IgAN) Patient Baseline Characteristics in Asian Versus Non-Asian Regions in the Sparsentan PROTECT Study

Posters IgAN

Proteinuria and its association with disease progression in IgA nephropathy: Analysis of the UK National RaDaR IgA nephropathy cohort

Contact Us

For more information, please click on the link below to be directed to our contact us form.

Adverse Event Reporting

To report suspected adverse reactions, contact Travere Therapeutics at 1-877-659-5518 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.